Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 5, 2014
|
| In: |
The lancet. Oncology
Year: 2014, Volume: 15, Issue: 4, Pages: 415-423 |
| ISSN: | 1474-5488 |
| DOI: | 10.1016/S1470-2045(14)70063-4 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/S1470-2045(14)70063-4
|
| Author Notes: | Ian Judson, Jaap Verweij, Hans Gelderblom, Jörg T Hartmann, Patrick Schöffski, Jean-Yves Blay, J Martijn Kerst, Josef Sufl iarsky, Jeremy Whelan, Peter Hohenberger, Anders Krarup-Hansen, Thierry Alcindor, Sandrine Marreaud, Saskia Litière, Catherine Hermans, Cyril Fisher, Pancras C W Hogendoorn, A Paolo dei Tos, Winette T A van der Graaf, for the European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group |
| Item Description: | Gesehen am: 24.11.2016 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1474-5488 |
| DOI: | 10.1016/S1470-2045(14)70063-4 |